replic
avian
infecti
bronchiti
viru
permiss
cell
block
cell
enucl
irradi
ultraviolet
light
prior
infect
cell
sre
treat
aamanitin
viru
growth
cycl
coronaviru
like
influenza
viru
replic
normal
presenc
cramanitin
chines
hamster
ovari
cell
possess
drugresist
rna
polymeras
ii
find
indic
avian
infecti
bronchiti
viru
requir
intact
cell
nucleu
one
host
transcript
function
product
infect
preliminari
data
suggest
cellular
function
involv
aspect
virusdirect
rna
synthesi
variou
member
coronaviru
group
recent
shown
contain
singlestrand
rna
genom
posit
messeng
polar
schochetman
et
al
lomniczi
kennedi
lai
stohlman
sinc
firmli
establish
whether
replic
prototyp
coronaviru
avian
infecti
bronchiti
viru
ibv
restrict
cytoplasm
site
whether
product
infect
riboviru
regul
part
unidentifi
host
factor
mcintosh
tyrrel
et
al
undertook
present
investig
ibv
biogenesi
util
inhibitor
compromis
normal
function
host
cell
transcript
apparatu
conduct
work
recent
report
human
coronaviru
block
infecti
viru
product
virusdirect
rna
synthesi
cell
treat
actinomycin
kennedi
johnsonlussenberg
similar
observ
sinc
made
extend
laboratori
ibv
evan
welsh
simpson
prepar
find
present
report
establish
ibv
replic
requir
activ
particip
intact
cell
nucleu
reprint
request
address
also
demonstr
avian
coronaviru
resembl
influenza
viru
need
function
compet
host
cell
dna
dnadepend
rna
polymeras
ii
product
infect
mahi
et
al
lamb
choppin
spooner
barri
howev
fmd
ibv
differ
influenza
viru
abl
stimul
uptak
rna
precursor
actinomycin
ad
cell
time
infect
virus
cell
highli
eggadapt
beaudett
strain
ibv
use
throughout
prepar
egggrown
stock
ibv
previous
describ
schochetman
et
az
case
egg
incub
hr
work
stock
influenza
viru
wsn
strain
prepar
allanto
infect
lodayold
white
leghorn
embryon
chicken
egg
vesicular
stomat
viru
vsv
indiana
strain
herp
simplex
viru
type
grown
cell
hr
use
reinforc
mem
rmem
medium
bablanian
et
al
contain
heatinactiv
fetal
calf
serum
fc
tryptos
phosphat
broth
tpb
clone
cell
obtain
american
type
cultur
collect
grown
subconflu
monolay
rmem
fc
petri
dish
cultur
use
plaqu
assay
viral
growth
experi
describ
line
cramanitinsensit
cho
resist
chor
chines
hamster
ovari
cell
origin
isol
laboratori
dr
lou
siminovitch
chan
et
al
provid
dr
purnel
choppin
line
maintain
rmem
contain
fc
supplementari
prolin
pgml
mdck
cell
use
plaqu
assay
wsn
influenza
viru
origin
obtain
dr
robert
krug
maintain
rmem
contain
fc
plaqu
assay
egg
infect
titrat
abstr
int
congr
virol
p
recent
demonstr
beaudett
strain
ibv
strain
grow
product
produc
plaqu
cell
despit
earlier
report
cell
nonpermiss
avian
coronaviru
yamada
et
al
otsuki
et
al
also
found
cell
support
ibvbeaudett
replic
plaqu
assay
ml
aliquot
lofold
viru
dilut
made
balanc
salt
solut
bss
contain
gelatin
gbss
schochetman
et
al
inocul
subconflu
monolay
cultur
cell
viru
adsorpt
carri
min
room
temperatur
plate
receiv
aliquot
eagl
mem
contain
fc
tpb
agaros
seakem
rockland
main
certain
lot
fetal
calf
serum
found
contain
factor
inhibitori
ibv
plaqu
product
make
necessari
screen
serum
commerci
sourc
suitabl
plate
incub
day
humidifi
atmospher
co
air
titrat
wsn
viru
perform
mdck
monolay
cultur
incub
day
serum
omit
overlay
plaqu
visual
subsequ
addit
mem
overlay
contain
neutral
red
fmal
concentr
egg
infect
titrat
perform
previous
describ
schochetman
et
al
infect
enucl
cell
techniqu
enucl
cell
fashion
method
carter
modifi
accord
specif
need
subconflu
sheet
cell
establish
wall
glass
corex
tube
x
mm
wash
free
growth
medium
bss
prewarm
aliquot
rmem
contain
pgml
cytochalasin
b
ad
tube
immedi
centrifug
prewarm
rotor
g
min
centrifug
drugcontain
medium
replac
regular
rmem
contain
fc
cultur
held
room
temperatur
cell
regain
approxim
normal
morpholog
min
control
cultur
treat
similarli
except
either
centrifug
drug
treatment
centrifug
without
subsequ
drug
treatment
degre
enucl
estim
stain
drugtreat
cultur
hematoxylin
eosin
count
number
nucleat
cell
among
total
cell
number
cell
per
cultur
estim
count
trypsindispers
cell
aid
hemocytomet
treat
untreat
cultur
infect
ibv
input
multipl
egg
infecti
unit
eiu
per
cell
adsorpt
viru
min
cell
wash
twice
bss
addit
rmem
contain
fc
tpb
cultur
incub
hr
postadsorpt
cultur
frozenthaw
result
lysat
clarifi
assay
viru
content
plaqu
cell
control
procedur
describ
follow
use
vsv
infect
determin
uridin
incorpor
subconflu
cell
monolay
petri
dish
expos
ibvbeaudett
input
multipl
eiucel
min
infect
cultur
receiv
ml
rmem
fc
tpb
aamanitin
pglml
ad
one
group
cultur
immedi
adsorpt
time
anoth
group
cultur
first
incub
hr
postadsorpt
group
cell
incub
cuamanitin
hr
medium
replac
rmem
contain
actinomycin
pgml
hr
later
cultur
receiv
uci
per
plate
uridin
thereaft
cell
monolay
pulselabel
hr
wash
three
time
cold
bss
remov
scrape
sediment
lowspe
centrifug
pack
cell
ad
ml
cold
trichloroacet
acid
tca
precipit
form
overnight
incub
collect
schleicher
cellulos
nitrat
filter
precipit
wash
five
time
aliquot
cold
tca
cold
ethanol
dri
filter
incub
hr
room
temperatur
liquid
scintil
vial
contain
ml
h
ml
protosol
new
england
nuclear
boston
mass
lml
addit
benzoyl
peroxid
icn
pharmaceut
plainview
n
protosol
made
vial
agit
mechan
min
ml
toluenebas
cocktail
g
ppo
g
dimethylpopoplit
toluen
contain
ascorb
acid
ad
vial
count
radioact
beckman
scintil
counter
use
extern
tritium
standard
chemic
aamanitin
obtain
sigma
chemic
co
st
loui
mo
actinomycin
gift
dr
j
oliv
lampen
institut
cytochalasin
b
obtain
aldrich
chemic
compani
inc
milwauke
wi
uridin
specif
activ
cimmol
obtain
new
england
nuclear
boston
mass
cell
previou
studi
capac
enucl
cell
support
replic
variou
anim
virus
exclud
analysi
repres
coronavirus
although
positivestrand
virus
test
follett
et
al
picornavirus
alphavirus
flavivirus
bunyavirus
exhibit
strict
requir
either
nuclear
factor
cellular
transcript
follett
et
al
obijeski
murphi
goldman
et
al
order
establish
import
host
nuclear
fimc
sheet
cell
attach
wall
glass
corex
tube
x
mm
expos
pgml
cytochalasin
b
centrifug
g
describ
materi
method
treat
cell
infect
either
ibv
eiu
per
cell
vsvindiana
pfukel
infect
cell
incub
rmem
medium
vsv
ibv
hr
titrat
viru
content
plaqu
assay
normal
cell
control
includ
cell
centrifug
treat
cytochalasin
prior
infect
combin
drug
treatment
centrifug
result
enucl
attach
cell
tion
ibv
replic
cycl
cell
enucl
treatment
cytochalasin
b
see
materi
method
test
permiss
inabl
cytoplast
deriv
cell
support
replic
ibvbeaudett
illustr
data
present
tabl
sinc
appreci
number
cell
detach
cultur
vessel
result
centrifug
viru
titer
accur
express
number
infecti
particl
pfu
per
cell
control
cell
expos
cytochalasin
without
centrifug
show
slight
reduct
virusproduc
capac
indic
drug
exert
strong
cytotox
effect
cell
contrast
result
obtain
ibv
replic
rhabdoviru
vsv
enucl
cell
nearli
effici
infect
carri
intact
cell
result
twoto
threefold
reduct
pfu
yield
vsv
enucl
cell
compar
control
may
partli
attribut
reduct
amount
cytoplasm
occur
enucl
process
describ
previous
investig
wiktor
koprowski
treat
cwamanitin
ibv
replic
enucl
cell
describ
also
observ
actinomycin
block
product
human
avian
coronavirus
without
impair
virusinduc
uptak
rna
precursor
kennedi
johnsonlussenberg
evan
welsh
simpson
prepar
sinc
enucl
actinomycin
also
known
abort
myxoviru
infect
kelli
et
al
barri
rott
et
al
market
al
wish
determin
whether
ibv
like
influenza
viru
might
requir
function
specif
nuclear
rna
polymeras
growth
cycl
permiss
cell
mahi
et
al
lamb
choppin
spooner
barri
ibv
grown
yamanitintr
cell
hr
describ
fig
drug
concentr
ugml
titer
ibv
untreat
infect
control
cultur
wsn
influenza
viru
also
strongli
inhibit
aamanitin
test
condit
employ
wherea
vsv
cytoplasm
riboviru
insensit
cyamanitin
concentr
rang
employ
fig
find
product
infect
cell
ibv
abort
yamanitin
suggest
nuclear
rna
polymeras
ii
play
unexpectedli
import
role
replic
positivestrand
viru
sinc
recogn
enzym
preferenti
inhibit
drug
appropri
concentr
roeder
demonstr
conclus
one
host
transcript
function
mediat
rna
polymeras
ii
regul
ibv
infect
compar
abil
ibv
replic
aamanitinresist
mutant
cho
cell
presenc
absenc
drug
sinc
cell
known
possess
aamanitinresist
form
enzym
lobban
et
al
cell
enabl
one
determin
action
aamanitin
due
direct
effect
cellular
rna
polymeras
ii
rather
viricid
action
secondari
effect
cell
wsn
influenza
viru
includ
control
experi
sinc
earlier
studi
shown
myxoviru
product
infect
chor
cell
presenc
aamanitin
lamb
choppin
spooner
barri
experi
summar
tabl
show
ibv
like
influenza
viru
replic
almost
equal
well
untreat
aamanitintr
chor
cell
wherea
virus
strongli
inhibit
progenitor
cho
cell
presenc
drug
note
peak
yield
ibvbeaudett
untreat
cho
chor
cell
substanti
less
obtain
cell
line
thu
indic
semipermiss
natur
coronaviru
collect
result
provid
evid
normal
function
cellular
rna
polymeras
ii
requir
coronaviru
replic
cell
system
examin
cho
cell
sensit
cho
resist
chor
inhibitori
effect
aamanitin
infect
either
ibv
influenza
wsn
viru
input
multipl
eiukel
ibv
pfukel
wsn
infect
cell
incub
hr
rmem
medium
presenc
absenc
gml
aamanitin
assay
plaqueform
viru
either
cell
ibv
mdck
cell
wsn
viru
cell
treat
olamamitin
actinomycin
use
actinomycin
low
concentr
inhibit
cellular
coronavirusdirect
incorpor
rna
precursor
kennedi
johnsonlussenberg
evan
welsh
simpson
prepar
furthermor
sinc
found
ibv
infect
cell
strongli
inhibit
host
cell
rna
synthesi
necessari
treat
cell
actinomycin
permit
monitor
virusspecif
rna
synthesi
examin
effect
yamanitin
viral
rna
synthesi
cell
expos
hr
aamanitin
either
immedi
viru
adsorpt
time
hr
later
shown
tabl
infect
cell
treat
actinomycin
gave
twofold
higher
incorpor
level
uninfect
control
reflect
virusspecif
rna
synthesi
aamanitin
ad
time
hr
postinfect
virusinduc
uridin
incorpor
could
measur
sinc
total
cellular
rna
synthesi
strongli
inhibit
drug
sequenti
treatment
ibvinfect
cell
aamanitin
actinomycin
fl
confluent
monolay
cultur
cell
infect
ibvbeaudett
input
eiukel
cultur
receiv
rmem
medium
contain
aamanitin
pgml
either
immedi
adsorpt
group
incub
cultur
hr
postinfect
group
b
follow
incub
cell
aamanitin
hr
medium
replac
rmem
contain
actinomycin
fglml
min
later
cultur
pulselabel
hr
icultur
uridin
sp
act
wmmol
thereaft
cell
process
determin
acidinsolubl
radioact
describ
materi
method
control
cultur
receiv
regular
rmem
place
medium
contain
either
actinomycin
aamanitin
appropri
time
interv
disintegr
per
minut
uninfect
cell
presenc
actinomycin
show
reduct
radioisotop
incorpor
comparison
untreat
control
respect
result
suppress
ment
cell
monolay
expos
virusspecif
rna
synthesi
whether
uv
light
sourc
differ
time
interv
cuamanitin
ad
time
hr
postwer
infect
ibvbeaudett
find
indic
hr
yield
assay
infect
sensit
virusdirect
rna
synthesi
result
experi
fig
clearli
cuamanitin
strictli
confin
show
treatment
render
earli
stage
ibv
replic
cell
nonpermiss
ibv
wsn
cell
also
possibl
suppress
influenza
convers
found
vsv
uridin
uptak
infect
cell
obwa
abl
sustain
product
infect
serv
experi
partli
reflect
cell
condit
addit
effect
two
drug
employ
irradi
uv
data
shown
also
examin
ultraviolet
radiat
inhibitor
cellular
dna
function
known
compromis
replic
anim
virus
influenza
barri
rott
et
al
vaccinia
viru
hrubi
et
al
establish
whether
growth
ibv
also
sensit
treat
experiment
approach
use
investig
demonstr
requir
function
compet
cell
nucleu
cellular
polymeras
ii
replic
infecti
bronchiti
viru
first
physic
remov
nuclei
cell
treatment
cytochalasin
b
render
cell
nonpermiss
ibv
io
durat
uv
treatment
second
fig
rel
yield
ibv
cell
expos
differ
dose
uv
light
prior
infect
subconflu
cell
monolay
irradi
interv
set
distanc
em
light
lamp
gener
electr
bulb
ibv
eiukel
wsn
influenza
viru
pfucel
ad
duplic
plate
irradi
time
interv
adsorb
hr
infect
cultur
incub
hr
ml
aliquot
rmem
fc
cell
lysat
obtain
freezingthaw
test
viru
content
plaqu
assay
either
cell
ibv
beaudett
without
impair
capac
replic
cytoplasm
riboviru
vsv
yet
determin
whether
virusspecif
macromolecular
synthesi
occur
ibvinfect
cytoplast
absenc
infecti
viru
product
whether
activ
detect
enucl
infect
posit
strand
coronaviru
depend
specif
mode
replic
whether
initi
viral
rna
synthesi
earli
process
viral
mrna
speci
nucleusdepend
event
work
progress
aim
understand
ibv
interact
nuclear
cytoplasm
compart
biosynthesi
hope
resolv
question
second
shown
treatment
permiss
cell
potent
fungal
toxin
cuamanitin
markedli
inhibit
product
infect
ibv
wsn
influenza
viru
low
concentr
gml
drug
recogn
act
rel
specif
inhibitor
dnadepend
rna
polymeras
ii
nuclear
enzym
eucaryot
cell
respons
messeng
rna
synthesi
roeder
rigor
proof
obligatori
role
rna
polymeras
ii
ibv
replic
cycl
found
experi
involv
cramanitinresist
chor
mutant
cell
line
possess
rna
polymeras
ii
insensit
drug
lobban
et
al
confirm
earlier
report
influenza
viru
resist
inhibitori
effect
aamanitin
grown
chor
cell
lamb
choppin
spooner
barri
extend
find
avian
coronaviru
ibv
similar
approach
recent
use
silver
et
al
implic
rna
polymeras
ii
essenti
host
factor
requir
poxviru
biogenesi
final
possibl
abort
infecti
viru
product
ibv
cell
irradi
uv
light
prior
infect
gener
pyrimidin
dimer
nucleic
acid
molecul
treatment
known
block
normal
host
dna
replic
rna
transcript
uv
dose
employ
experi
would
expect
strongli
inhibit
dna
rna
synthesi
cf
hrubi
et
al
thu
although
uv
irradi
simultan
inhibit
number
cellular
biosynthet
activ
clear
radiationdamag
cell
function
impair
nuclei
unabl
support
activ
replic
infecti
ibv
particl
interest
outcom
studi
ibv
realiz
rna
viru
grossli
resembl
negativestrand
myxovirus
sensit
growth
cycl
experiment
condit
compromis
either
cell
nucleu
kelli
et
al
normal
dna
function
barri
rott
et
al
nuclear
rna
polymeras
ii
activ
mahi
et
al
lamb
choppin
spooner
barri
alreadi
quit
appar
howev
two
dispar
class
anim
ribovirus
differ
molecular
level
requir
specif
host
factor
viral
replic
cycl
found
inhibitor
function
cellular
dna
actinomycin
mitomycin
c
strongli
block
product
infecti
ibv
progeni
cell
evan
welsh
simpson
prepar
unlik
influenza
viru
howev
growth
ibv
remain
sensit
actinomyein
rel
late
infect
throughout
time
cours
drug
appreci
effect
virusinduc
sustain
uptak
radiolabel
rna
precursor
kennedi
johnsonlussenburg
observ
similar
effect
actinomycin
biogenesi
human
coronaviru
cell
although
conclud
drug
princip
activ
earli
stage
viral
growth
cycl
none
experi
exclud
possibl
actinomycin
prevent
transcript
shortliv
host
mrna
essenti
viral
replic
anoth
possibl
transport
essenti
rna
speci
nucleu
cytoplasm
site
viral
biosynthesi
block
action
drug
levi
penman
intrigu
unansw
question
concern
precis
role
host
rna
polymeras
ii
ibv
replic
cycl
specif
inhibit
enzym
ibvinfect
cell
cyamanitin
negat
virusstimul
uridin
incorpor
normal
insensit
inhibitori
effect
actinomycin
determin
whether
appear
normal
size
class
ibvspecif
rna
prevent
cell
cramanitin
preliminari
sign
initi
possibl
mainten
viral
rna
synthesi
depend
function
integr
nuclear
rna
polymeras
ii
influenza
viru
convinc
evid
eucaryot
enzym
provid
host
mrna
primer
serv
initi
viral
rna
transcript
cell
nucleu
mark
et
al
plotch
et
al
rna
polymeras
ii
multicompon
enzym
exist
least
three
structur
distinct
form
directli
implic
synthesi
viral
mrna
precursor
variou
dna
virus
rna
retrovirus
roeder
avian
coronavirus
credit
possess
largest
singlestrand
rna
genom
lomniczi
kennedi
manner
replic
present
unknown
robb
bond
one
possibl
ibv
positivestrand
coronavirus
util
viruscod
rnadepend
rna
polymeras
hybrid
enzym
contain
one
host
compon
includ
specif
subunit
deriv
nuclear
rna
polymeras
ii
preced
multicompon
viral
enzym
mix
origin
alreadi
well
document
procaryot
speci
losik
pero
